Works matching IS 2253-1556 AND VI 13 AND DT 2024
Results: 56
TRPC6 is a Biomarker for Prognosis and Immunotherapy of Stomach Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 735, doi. 10.2147/ITT.S488953
- By:
- Publication type:
- Article
The Potential Value of RPS27A in Prognosis and Immunotherapy: From Pan-Cancer Analysis to Hepatocellular Carcinoma Validation.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 673, doi. 10.2147/ITT.S493217
- By:
- Publication type:
- Article
NLRP3 Inflammasome Upregulates PD-L1 in Ovarian Cancer and Contributes to an Immunosuppressive Microenvironment.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 775, doi. 10.2147/ITT.S495564
- By:
- Publication type:
- Article
Advances in B Cell Targeting for Treating Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 707, doi. 10.2147/ITT.S492062
- By:
- Publication type:
- Article
Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 749, doi. 10.2147/ITT.S486731
- By:
- Publication type:
- Article
Lipopolysaccharide in Bile Promotes the Neutrophil Extracellular Traps-Induced Gallstone Formation by Activating the Gallbladder Immune Barrier.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 789, doi. 10.2147/ITT.S495095
- By:
- Publication type:
- Article
Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Based on EcoTyper Machine Learning Framework Identifies Cell-State-Specific M2 Macrophage Markers Associated with Gastric Cancer Prognosis.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 721, doi. 10.2147/ITT.S490075
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitor Combined with Antiangiogenic Agent Synergistically Improving the Treatment Efficacy for Solid Tumors.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 813, doi. 10.2147/ITT.S494670
- By:
- Publication type:
- Article
Evolution of Hematobiochemical Profiles in Newly Diagnosed HIV Patients and HIV-TB Co-Infected Patients: Correlation with Immunological and Virological Status.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 691, doi. 10.2147/ITT.S495295
- By:
- Publication type:
- Article
Diminished Diversities and Clonally Expanded Sequences of T-Cell Receptors in Patients with Chronic Spontaneous Urticaria.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 661, doi. 10.2147/ITT.S481361
- By:
- Publication type:
- Article
Anti-GluK2 Encephalitis in an Asian Child: A Case Report and Literature Review.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 805, doi. 10.2147/ITT.S498345
- By:
- Publication type:
- Article
The Effect of Circulating Inflammatory Proteins on Endometriosis: A Mendelian Randomization Study.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 585, doi. 10.2147/ITT.S486139
- By:
- Publication type:
- Article
Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 643, doi. 10.2147/ITT.S463556
- By:
- Publication type:
- Article
Novel Insights into Causal Effects of Lipid and Lipid-Lowering Targets with Autoimmune Thyroid Disease: A Mendelian Randomization Study.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 631, doi. 10.2147/ITT.S487319
- By:
- Publication type:
- Article
Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of T<sub>h</sub>2 Cells as Therapeutic Concept in COVID-19 Infection.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 595, doi. 10.2147/ITT.S463601
- By:
- Publication type:
- Article
Causality Between 91 Circulating Inflammatory Proteins and Various Asthma Phenotypes: A Mendelian Randomization Study.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 617, doi. 10.2147/ITT.S486676
- By:
- Publication type:
- Article
Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 571, doi. 10.2147/ITT.S483093
- By:
- Publication type:
- Article
Harnessing Variability Signatures and Biological Noise May Enhance Immunotherapies' Efficacy and Act as Novel Biomarkers for Diagnosing and Monitoring Immune-Associated Disorders.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 525, doi. 10.2147/ITT.S477841
- By:
- Publication type:
- Article
The Efficacy and Safety of Bevacizumab Plus Anti-PD-1/PD-L1 Inhibitors in Combination with Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 559, doi. 10.2147/ITT.S478685
- By:
- Publication type:
- Article
Assessing the Prognostic Value of 13 Inflammation-Based Scores in Patients with Unresectable or Advanced Biliary Tract Carcinoma After Immunotherapy.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 541, doi. 10.2147/ITT.S471502
- By:
- Publication type:
- Article
A Self-Activating IL-15 Chimeric Cytokine Receptor to Empower Cancer Immunotherapy.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 513, doi. 10.2147/ITT.S490498
- By:
- Publication type:
- Article
Thrombopoietin Receptor Agonists in Post-Hematopoietic Cell Transplantation Complicated by Prolonged Thrombocytopenia: A Comprehensive Review.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 461, doi. 10.2147/ITT.S463384
- By:
- Publication type:
- Article
Survival Benefit of Lenvatinib Plus PD-1 Inhibitor with or Without HAIC in Advanced Hepatocellular Carcinoma Beyond Oligometastasis: a Multicenter Cohort Study.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 447, doi. 10.2147/ITT.S477972
- By:
- Publication type:
- Article
EPS T14 from Bacillus licheniformis Prevents Infection of Human Nasal Epithelial Cells by Respiratory Viruses.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 487, doi. 10.2147/ITT.S470319
- By:
- Publication type:
- Article
Clinical Significance and Molecular Annotation for PD-L1 Negative Advanced Non-Small Cell Lung Cancer with Sensitivity to Responsive to Dual PD-1/CTLA-4 Blockade.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 435, doi. 10.2147/ITT.S476040
- By:
- Publication type:
- Article
Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 501, doi. 10.2147/ITT.S479153
- By:
- Publication type:
- Article
Revolutionizing Immunotherapy: Unveiling New Horizons, Confronting Challenges, and Navigating Therapeutic Frontiers in CAR-T Cell-Based Gene Therapies.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 413, doi. 10.2147/ITT.S474659
- By:
- Publication type:
- Article
Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 399, doi. 10.2147/ITT.S470797
- By:
- Publication type:
- Article
Clinical Features and Pathology of PLA2R and THSD7A-Associated Membranous Nephropathy: A Single-Center Study from China.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 385, doi. 10.2147/ITT.S450413
- By:
- Publication type:
- Article
Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 367, doi. 10.2147/ITT.S276869
- By:
- Publication type:
- Article
Mycobacterium tuberculosis Biofilms: Immune Responses, Role in TB Pathology, and Potential Treatment.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 335, doi. 10.2147/ITT.S455744
- By:
- Publication type:
- Article
Mapping Single-Cell Transcriptomes of Endometrium Reveals Potential Biomarkers in Endometrial Cancer.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 349, doi. 10.2147/ITT.S470994
- By:
- Publication type:
- Article
A Case Report of Pathologically Complete Response of a Huge Lymph Node Metastasis of Colorectal Cancer After Treatment with Intratumoral Oncolytic Virus H101 and Capecitabine.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 305, doi. 10.2147/ITT.S458700
- By:
- Publication type:
- Article
Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer's Disease.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 287, doi. 10.2147/ITT.S455881
- By:
- Publication type:
- Article
Deciphering Natural Killer Cell Cytotoxicity Against Medulloblastoma in vitro and in vivo: Implications for Immunotherapy.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 319, doi. 10.2147/ITT.S458278
- By:
- Publication type:
- Article
Mendelian Randomization Analysis of Circulating Cytokines and Risk of Autoimmune Neuroinflammatory Diseases.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 273, doi. 10.2147/ITT.S456326
- By:
- Publication type:
- Article
Targeted siRNA Therapy for Psoriasis: Translating Preclinical Potential into Clinical Treatments.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 259, doi. 10.2147/ITT.S458800
- By:
- Publication type:
- Article
Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 247, doi. 10.2147/ITT.S452339
- By:
- Publication type:
- Article
Clinical Significance of Uncommon, Non-Clinical, and Novel Autoantibodies.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 215, doi. 10.2147/ITT.S450184
- By:
- Publication type:
- Article
The Role of Extracorporeal Photopheresis in the Management of Graft Versus Host Disease: Narrative Review.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 235, doi. 10.2147/ITT.S457366
- By:
- Publication type:
- Article
Correlation Between C4/IgG with Macroproteinuria in Chronic Kidney Disease: A Pilot Study.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 205, doi. 10.2147/ITT.S451307
- By:
- Publication type:
- Article
Comprehension of Calcitriol Levels in Pregnant Women With Latent Tuberculosis and Immune Function in their Newborns.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 195, doi. 10.2147/ITT.S436765
- By:
- Publication type:
- Article
Thymic NK-Cells and Their Potential in Cancer Immunotherapy.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 183, doi. 10.2147/ITT.S441639
- By:
- Publication type:
- Article
Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 123, doi. 10.2147/ITT.S446938
- By:
- Publication type:
- Article
Cold Tumour Phenotype Explained Through Whole Genome Sequencing in Clinical Nasopharyngeal Cancer: A Preliminary Study.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 173, doi. 10.2147/ITT.S452117
- By:
- Publication type:
- Article
Dermatomyositis: Practical Guidance and Unmet Needs.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 151, doi. 10.2147/ITT.S381472
- By:
- Publication type:
- Article
Unveiling Dynamic Changes and Regulatory Mechanisms of T Cell Subsets in Sepsis Pathogenesis.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 29, doi. 10.2147/ITT.S448691
- By:
- Publication type:
- Article
Males' Access to Human Papillomavirus Vaccination in Resource-Limited Settings.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 95, doi. 10.2147/ITT.S451659
- By:
- Publication type:
- Article
Inhibition Effect of Pancreatic Exocrine Insufficiency on Immune Checkpoint Inhibitor Treatment in Pancreatic Cancer: A Retrospective Study.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 45, doi. 10.2147/ITT.S442247
- By:
- Publication type:
- Article